4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-027205
Options or other derivatives
- EVP, Chief Financial Officer acquired 117,195 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-05-01 | Grant or award · Stock Options (Right to Buy) | +89,936 | 89,936 | D | ||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-05-01 | Grant or award · Restricted Stock Units | +27,259 | 27,259 | D | ||
Loading xslF345X04/doc4.xml…